Skip to content
1887

Microbiology Society logo Microbiology

Volume 152, Issue 1

Phenotypic switching in Free

Abstract

Phenotypic switching has been described in serotype A and D strains of . It occurs during chronic infection and is associated with differential gene expression and changes in virulence. The switch involves changes in the polysaccharide capsule and cell wall that affect the yeast's ability to resist phagocytosis. In addition, the phenotypic switch variants elicit qualitatively different inflammatory responses in the host. In animal models of chronic cryptococosis, the immune response of the host ultimately determines which of the switch variants are selected and maintained. The importance of phenotypic switching is further underscored by several findings that are relevant in the setting of human disease. These include the ability of the mucoid colony variant of RC-2 (RC-2 MC) but not the smooth variant (RC-2 SM) to promote increased intracerebral pressure in a rat model of cryptococcal meningitis. Furthermore, chemotherapeutic and immunological antifungal interventions can promote the selection of the RC-2 MC variant during chronic murine infection.

  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.28451-0
2006-01-01
2025-05-20
Loading full text...

Full text loading...

/deliver/fulltext/micro/152/1/3.html?itemId=/content/journal/micro/10.1099/mic.0.28451-0&mimeType=html&fmt=ahah

References

  1. Brandt M. E, Pfaller M. A, Hajjeh R. A, Graviss E. A, Rees J, Spitzer E. D, Pinner R. W, Mayer L. W. 1996; Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated cryptococcosis. Cryptococcal Disease Active Surveillance Group. J Infect Dis 174:812–820 [CrossRef]
     [Google Scholar]
  2. Brandt M. E, Pfaller M. A, Hajjeh R. A, Hamill R. J, Pappas P. G, Reingold A. L, Rimland D, Warnock D. W. 2001; Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother 45:3065–3069 [CrossRef]
     [Google Scholar]
  3. Bulmer G. S, Sans M. D. 1968; Cryptococcus neoformans . III. Inhibition of phagocytosis. J Bacteriol 95:5–8
     [Google Scholar]
  4. Casadevall A, Pirofski L. A. 1999; Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun 67:3703–3713
     [Google Scholar]
  5. Casadevall A, Pirofski L. 2001; Host-pathogen interactions: the attributes of virulence. J Infect Dis 184:337–344 [CrossRef]
     [Google Scholar]
  6. Chao L, Vargas C, Spear B, Cox E. 1983; Transposable elements as mutator genes in evolution. Nature 303:633–635 [CrossRef]
     [Google Scholar]
  7. Chen L. C, Casadevall A. 1999; Variants of a Cryptococcus neoformans strain elicit different inflammatory responses in mice. Clin Diagn Lab Immunol 6:266–268
     [Google Scholar]
  8. Cherniak R, Morris L. C, Belay T, Spitzer E. D, Casadevall A. 1995; Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect Immun 63:1899–1905
     [Google Scholar]
  9. Cherniak R, Valafar H, Morris L, Valafar F. 1998; Cryptococcus neoformans chemotyping by quantitative analysis of [sup]1[/sup]H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin Diagn Lab Immunol 5:146–159
     [Google Scholar]
  10. Currie B, Sanati H, Ibrahim A. S, Ghannoum M. A, Edwards J. E., Jr, Casadevall A. 1995; Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage. Antimicrob Agents Chemother 39:1934–1937 [CrossRef]
     [Google Scholar]
  11. Deitsch K. W, Moxon E. R, Wellems T. E. 1997; Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiol Mol Biol Rev 61:281–293
     [Google Scholar]
  12. D'Souza C. A, Heitman J. 2001; It infects me, it infects me not: phenotypic switching in the fungal pathogen Cryptococcus neoformans . J Clin Invest 108:1577–1578 [CrossRef]
     [Google Scholar]
  13. Ebert D. 1998; Experimental evolution of parasites. Science 282:1432–1435 [CrossRef]
     [Google Scholar]
  14. Eissenberg L. G, Poirier S, Goldman W. E. 1996; Phenotypic variation and persistence of Histoplasma capsulatum yeasts in host cells. Infect Immun 64:5310–5314
     [Google Scholar]
  15. Feldmesser M, Kress Y, Novikoff P, Casadevall A. 2000; Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 68:4225–4237 [CrossRef]
     [Google Scholar]
  16. Feldmesser M, Kress Y, Casadevall A. 2001; Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147:2355–2365
     [Google Scholar]
  17. Franzot S, Mukherjee J, Cherniak R, Chen L, Hamdan J, Casadevall A. 1998; Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 66:89–97
     [Google Scholar]
  18. Fries B. C, Casadevall A. 1998; Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. J Infect Dis 178:1761–1766 [CrossRef]
     [Google Scholar]
  19. Fries B. C, Chen F, Currie B. P, Casadevall A. 1996; Karyotype instability in Cryptococcus neoformans infection. J Clin Microbiol 34:1531–1534
     [Google Scholar]
  20. Fries B. C, Goldman D. L, Cherniak R, Ju R, Casadevall A. 1999; Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect Immun 67:6076–6083
     [Google Scholar]
  21. Fries B. C, Taborda C. P, Serfass E, Casadevall A. 2001; Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest 108:1639–1648 [CrossRef]
     [Google Scholar]
  22. Fries B. C, Cook E, Wang X, Casadevall A. 2005a; Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans . Antimicrob Agents Chemother 49:350–357 [CrossRef]
     [Google Scholar]
  23. Fries B. C, Lee S. C, Kennan R, Zhao W, Casadevall A, Goldman D. L. 2005b; Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis. Infect Immun 73:1779–1787 [CrossRef]
     [Google Scholar]
  24. Goldman D, Fries B, Franzot S, Montella L, Casadevall A. 1998; Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. Proc Natl Acad Sci U S A 95:14967–14972 [CrossRef]
     [Google Scholar]
  25. Guerrero A, Jain N, Cook E, Casadevall A, Fries B. 2003; Phenotypic switch variants of Cryptococcus neoformans differ in gene expression profile. In 103rd General Meeting of the American Society for Microbiology Washington DC: Abstract F39
    [Google Scholar]
  26. Hammerschmidt S, Hilse R, Gerady-Schahn R, Unkmair A, Frosch M, van Putten J. 1996; Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J 15:192–198
     [Google Scholar]
  27. Jain N, Wickes B. L, Keller S. M, Fu J, Casadevall A, Jain P, Ragan M. A, Banerjee U, Fries B. J Clin Microbiol 43:5733–5742 [CrossRef]
     [Google Scholar]
  28. Klar A. J, Srikantha T, Soll D. R. 2001; A histone deacetylation inhibitor and mutant promote colony-type switching of the human pathogen Candida albicans . Genetics 158:919–924
     [Google Scholar]
  29. Kugler S, Schurtz Sebghati T, Groppe Eissenberg L, Goldman W. E. 2000; Phenotypic variation and intracellular parasitism by Histoplasma capsulatum . Proc Natl Acad Sci U S A 97:8794–8798 [CrossRef]
     [Google Scholar]
  30. Lachke S. A, Srikantha T, Tsai L. K, Daniels K, Soll D. R. 2000; Phenotypic switching in Candida glabrata involves phase-specific regulation of the metallothionein gene MT-II and the newly discovered hemolysin gene HLP. Infect Immun 68:884–895 [CrossRef]
     [Google Scholar]
  31. Levitz S. M, Nong S. H, Seetoo K. F, Harrison T. S, Speizer R. A, Simons E. R. 1999; Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect Immun 67:885–890
     [Google Scholar]
  32. Lysnynansky I, Rosengarten R, Yogev D. 1996; Phenotypic switching of variable surface lipoproteins in Mycoplasma bovis involves high-frequency chromosomal rearrangement. J Bacteriol 178:5395–5401
     [Google Scholar]
  33. Martin D. W, Schurr M. J, Mudd M. H, Govan J. R, Holloway B. W, Deretic V. 1993; Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci U S A 90:8377–8381 [CrossRef]
     [Google Scholar]
  34. Miller M. G, Johnson A. D. 2002; White-opaque switching in Candida albicans is controlled by mating-type locus homeodomain proteins and allows efficient mating. Cell 110:293–302 [CrossRef]
     [Google Scholar]
  35. Mirza S. A, Phelan M, Rimland D. 8 other authors 2003; The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992–2000. Clin Infect Dis 36:789–794 [CrossRef]
     [Google Scholar]
  36. Myler P, Allison J, Agabian N, Stuart K. 1984; Antigenic variation in African trypanosomes by gene replacement or activation of alternate telomeres. Cell 39:203–211 [CrossRef]
     [Google Scholar]
  37. Perez-Martin J, Uria J. A, Johnson A. D. 1999; Phenotypic switching in Candida albicans is controlled by a SIR2 gene. EMBO J 18:2580–2592 [CrossRef]
     [Google Scholar]
  38. Perfect J. R, Casadevall A. 2002; Cryptococcosis. Infect Dis Clin North Am 16:837–874 v–vi [CrossRef]
     [Google Scholar]
  39. Pfaller M. A, Zhang J, Messer S. A, Brandt M. E, Hajjeh R. A, Jessup C. J, Tumberland M, Mbidde E. K, Ghannoum M. A. 1999; In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother 43:169–171 [CrossRef]
     [Google Scholar]
  40. Pietrella D, Fries B, Lupo P, Bistoni F, Casadevall A, Vecchiarelli A. 2003; Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response. Cell Microbiol 5:513–522 [CrossRef]
     [Google Scholar]
  41. Powderly W. G. 2000; Current approach to the acute management of cryptococcal infections. J Infect 41:18–22 [CrossRef]
     [Google Scholar]
  42. Radford D, Challacombe S, Walter J. 1994; A scanning electron microscopy investigation of the structure of colonies of different morphologies produced by phenotypic switching in Candida albicans . J Med Microbiol 40:416–423 [CrossRef]
     [Google Scholar]
  43. Rustchenko-Bulgac E. 1991; Variations of Candida albicans electrophoretic karyotypes. J Bacteriology 19916586–6596
     [Google Scholar]
  44. Schwan T. G, Hinnebush B. J. 1998; Bloodstream- versus tick-associated variants of a relapsing fever bacterium. Science 280:1938–1940 [CrossRef]
     [Google Scholar]
  45. Silverman M, Zieg J, Hilmen M, Simon M. 1979; Phase variation in Salmonella : genetic analysis of a recombinational switch. Proc Natl Acad Sci U S A 76:391–395 [CrossRef]
     [Google Scholar]
  46. Sinha H, Pain A, Johnstone K. 2000; Analysis of the role of recA in phenotypic switching of Pseudomonas tolaasii . J Bacteriol 182:6532–6535 [CrossRef]
     [Google Scholar]
  47. Slutsky B, Buffo J, Soll D. R. 1985; High-frequency switching of colony morphology in Candida albicans . Science 230:666–669 [CrossRef]
     [Google Scholar]
  48. Slutsky B, Staebell M, Anderson J, Risen L, Pfaller M, Soll D. R. 1987; “White-opaque transition”: a second high-frequency switching system in Candida albicans . J Bacteriol 169:189–197
     [Google Scholar]
  49. Soll D. R. 1992; High-frequency switching in Candida albicans . Clin Microbiol Rev 5:183–203
     [Google Scholar]
  50. Soll D. R. 2002; Candida commensalism and virulence: the evolution of phenotypic plasticity. Acta Trop 81:101–110 [CrossRef]
     [Google Scholar]
  51. Soll D, Galask R, Isley S, Rao T, Stone D, Hicks J, Schmid J, Mac K, Hanna C. 1989; Switching of Candida albicans during successive episodes of recurrent vaginitis. J Clin Microbiol 27:681–690
     [Google Scholar]
  52. Spitzer E. D, Spitzer S. G, Freundlich L. F, Casadevall A. 1993; Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 341:595–596 [CrossRef]
     [Google Scholar]
  53. Srikantha T, Tsai L, Daniels K, Klar A. J, Soll D. R. 2001; The histone deacetylase genes HDA1 and RPD3 play distinct roles in regulation of high-frequency phenotypic switching in Candida albicans . J Bacteriol 183:4614–4625 [CrossRef]
     [Google Scholar]
  54. Steenbergen J. N, Shuman H. A, Casadevall A. 2001; Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci U S A 98:15245–15250 [CrossRef]
     [Google Scholar]
  55. Sukroongreung S, Lim S, Tantimavanich S, Eampokalap B, Carter D, Nilakul C, Kulkeratiyut S, Tansuphaswadikul S. 2001; Phenotypic switching and genetic diversity of Cryptococcus neoformans . J Clin Microbiol 39:2060–2064 [CrossRef]
     [Google Scholar]
  56. Swartley L, Marfin A, Edupuganti S, Liu L, Cieslak P, Perkins B, Wenger J. 1997; Capsule switching of Neisseria meningitidis . Proc Natl Acad Sci U S A 94:271–276 [CrossRef]
     [Google Scholar]
  57. True H. L, Lindquist S. L. 2000; A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407:477–483 [CrossRef]
     [Google Scholar]
  58. Vargas K, Messer S. A, Pfaller M, Lockhart S. R, Stapleton J. T, Hellstein J, Soll D. R. 2000; Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode. J Clin Microbiol 38:3595–3607
     [Google Scholar]
/content/journal/micro/10.1099/mic.0.28451-0
Loading
Phenotypic switching in Cryptococcus neoformans
Microbiology 152, 3 (2006); https://doi.org/10.1099/mic.0.28451-0
/content/journal/micro/10.1099/mic.0.28451-0
/content/journal/micro/10.1099/mic.0.28451-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error